![Helen Sabzevari](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Helen Sabzevari
Chief Executive Officer at
PRECIGEN, INC.
Net worth: 32 M $ as of 2026-09-29
Profile
Helen Sabzevari was the founder and Chief Scientific Officer at Compass Therapeutics LLC, which was founded in 2015.
She held this position from 2015 to 2017.
She is currently the President, Chief Executive Officer & Director at Precigen, Inc. since 2020 and the President at PGEN Therapeutics, Inc. since 2017.
Dr. Sabzevari has also served as an Independent Director at Kinnate Biopharma, Inc. from 2021 to 2024.
In addition, she was the Senior Vice President-Health Therapeutics at Precigen, Inc. in 2017 and the Global Head-Immunotherapy, Oncology & Research at EMD Serono, Inc. from 2008 to 2014.
Dr. Sabzevari holds a doctorate degree from The Scripps Research Institute.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
PRECIGEN INC 1.27% | 2026-08-22 | 3,779,521 ( 1.27% ) | 32 M $ | 2026-09-29 |
Helen Sabzevari active positions
| Companies | Position | Start |
|---|---|---|
| PRECIGEN, INC. | Chief Executive Officer | 2019-12-31 |
PGEN Therapeutics, Inc.
 PGEN Therapeutics, Inc. BiotechnologyHealth Technology Develops gene and cellular therapies | President | 2017-10-31 |
Former positions of Helen Sabzevari
| Companies | Position | End |
|---|---|---|
| KINNATE BIOPHARMA INC. | Director/Board Member | 2024-04-02 |
| PRECIGEN, INC. | Corporate Officer/Principal | 2017-10-31 |
Compass Therapeutics LLC
 Compass Therapeutics LLC BiotechnologyHealth Technology Operates in the healthcare industry focusing on biotechnology business | Founder | 2016-12-31 |
EMD Serono, Inc.
 EMD Serono, Inc. BiotechnologyHealth Technology Develops therapeutics and drug delivery devices for neurology, oncology & immunology | Chief Tech/Sci/R&D Officer | 2013-12-31 |
Education of Helen Sabzevari
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
65
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Precigen, Inc.
 Precigen, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company | Health Technology |
Compass Therapeutics LLC
Compass Therapeutics LLC BiotechnologyHealth Technology Operates in the healthcare industry focusing on biotechnology business | Health Technology |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EMD Serono, Inc.
EMD Serono, Inc. BiotechnologyHealth Technology Develops therapeutics and drug delivery devices for neurology, oncology & immunology | Health Technology |
PGEN Therapeutics, Inc.
PGEN Therapeutics, Inc. BiotechnologyHealth Technology Develops gene and cellular therapies | Health Technology |
Kinnate Biopharma, Inc.
 Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage precision oncology company | Health Technology |
- Stock Market
- Insiders
- Helen Sabzevari
